Egetis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:P0F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
26 Nov 25	Buy€98,865	Mats Blom	Individual		215,000	€0.47

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of P0F?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	66,935,567	14.4%
VC/PE Firms	77,264,048	16.6%
Individual Insiders	85,672,750	18.4%
General Public	103,116,976	22.2%
Institutions	131,957,883	28.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.4%.

Top Shareholders

Top 25 shareholders own 77.74% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.6%	Frazier Life Sciences Management, LP	77,264,048	€49.7m	17.7%	1.28%
10%	Peter Lindell	46,598,580	€30.0m	16.9%	no data
7.28%	Peder Walberg	33,852,091	€21.8m	0%	no data
7.26%	Cetoros AB	33,776,221	€21.7m	0%	no data
7.17%	Fourth Swedish National Pension Fund (AP4)	33,344,078	€21.5m	17.7%	0.08%
4.47%	Avla Holding AB	20,782,320	€13.4m	17.6%	no data
4.16%	The Invus Group, LLC	19,350,649	€12.5m	17.8%	30.06%
3.5%	Unionen	16,256,393	€10.5m	17.8%	4.53%
2.82%	Avanza Fonder AB	13,115,953	€8.4m	16.6%	0.08%
2.66%	Recipharm AB	12,377,026	€8.0m	17.5%	no data
2.09%	Linc AB	9,698,416	€6.2m	20.1%	3.15%
1.48%	Woodline Partners LP	6,881,257	€4.4m	17.6%	0.02%
1.37%	Swedbank Robur Fonder AB	6,373,245	€4.1m	18%	no data
1.3%	Handelsbanken Asset Management	6,065,409	€3.9m	0%	0.01%
1.05%	Flerie AB (publ)	4,885,231	€3.1m	0%	10.88%
1.02%	Nordnet AB (publ)	4,723,065	€3.0m	0%	0.3%
0.88%	BMO Asset Management Corp.	4,108,648	€2.6m	0%	no data
0.72%	Promepar Asset Management	3,362,851	€2.2m	0%	9.16%
0.72%	Mats Blom	3,349,762	€2.2m	-4.29%	no data
0.7%	Healthinvest Partners AB	3,272,688	€2.1m	0%	0.65%
0.11%	Financiere Arbevel	520,000	€334.7k	0%	0.09%
0.11%	Nicklas Westerholm	501,511	€322.8k	94.5%	no data
0.099%	Henrik Krook	459,593	€295.8k	0%	no data
0.066%	Yilmaz Mahshid	306,249	€197.1k	57.1%	no data
0.048%	Christian Sonesson	223,250	€143.7k	90.3%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/17 15:39
End of Day Share Price	2026/08/17 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Egetis Therapeutics AB (publ) is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Patrick Langstrom	ABG Sundal Collier Sponsored
Kristen Kluska	Cantor Fitzgerald & Co.
Ulrik Trattner	Carnegie Investment Bank AB